Clinical Trials Browser

OTHER × vorolanib × Gastrointestinal × Clear all

NCT03511222 2020-07-29

Vorolanib (X-82) Combined With Checkpoint Inhibitors in Patients With Solid Tumors

Phase 1 Terminated

Gastrointestinal

Carcinoma, Hepatocellular, Stomach Neoplasms